Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2021-01-28 2021-01-28
Drug Identification Number 02448327 02448327
Brand name ACT DEXTROAMPHETAMINE SR ACT DEXTROAMPHETAMINE SR
Common or Proper name DEXTROAMPHETAMINE SR CAP 15MG DEXTROAMPHETAMINE SR CAP 15MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DEXTROAMPHETAMINE SULFATE DEXTROAMPHETAMINE SULFATE
Strength(s) 15MG 15MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-18 2020-11-18
Estimated end date 2021-01-31 2021-01-31
Actual end date 2021-01-27 2021-01-27
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments